125 related articles for article (PubMed ID: 30173251)
21. VERO stable cell lines expressing full-length human epidermal growth factor receptors 2 and 3: platforms for subtractive phage display.
Hedayatizadeh-Omran A; Valadan R; Rafiei A; Tehrani M; Alizadeh-Navaei R
DNA Cell Biol; 2015 Sep; 34(9):573-8. PubMed ID: 26121156
[TBL] [Abstract][Full Text] [Related]
22. Superficial radiotherapy for patients with basal cell carcinoma: recurrence rates, histologic subtypes, and expression of p53 and Bcl-2.
Zagrodnik B; Kempf W; Seifert B; Müller B; Burg G; Urosevic M; Dummer R
Cancer; 2003 Dec; 98(12):2708-14. PubMed ID: 14669293
[TBL] [Abstract][Full Text] [Related]
23. The role of EGFR overexpression on the recurrence of basal cell carcinomas with positive surgical margins.
Biray Avci C; Kaya I; Ozturk A; Ozates Ay NP; Sezgin B; Kurt CC; Akyildiz NS; Bozan A; Yaman B; Akalin T; Apaydin F
Gene; 2019 Mar; 687():35-38. PubMed ID: 30419251
[TBL] [Abstract][Full Text] [Related]
24. HER3 expression in cutaneous tumors.
Wimmer E; Kraehn-Senftleben G; Issing WJ
Anticancer Res; 2008; 28(2A):973-9. PubMed ID: 18507044
[TBL] [Abstract][Full Text] [Related]
25. Nodular basal cell carcinoma is associated with increased hyaluronan homeostasis.
Tzellos TG; Kyrgidis A; Vahtsevanos K; Triaridis S; Printza A; Klagas I; Zvintzou E; Kritis A; Karakiulakis G; Papakonstantinou E
J Eur Acad Dermatol Venereol; 2011 Jun; 25(6):679-87. PubMed ID: 20849445
[TBL] [Abstract][Full Text] [Related]
26. Mitochondrial D310 D-Loop instability and histological subtypes in radiation-induced cutaneous basal cell carcinomas.
Boaventura P; Pereira D; Mendes A; Batista R; da Silva AF; Guimarães I; Honavar M; Teixeira-Gomes J; Lopes JM; Máximo V; Soares P
J Dermatol Sci; 2014 Jan; 73(1):31-9. PubMed ID: 24091058
[TBL] [Abstract][Full Text] [Related]
27. Presence of ulceration, but not high risk zone location, correlates with unfavorable histopathological subtype in facial basal cell carcinoma.
Yalcin O; Sezer E; Kabukcuoglu F; Kilic AI; Sari AG; Cerman AA; Altunay IK
Int J Clin Exp Pathol; 2015; 8(11):15448-53. PubMed ID: 26823913
[TBL] [Abstract][Full Text] [Related]
28. Erlotinib directly inhibits HER2 kinase activation and downstream signaling events in intact cells lacking epidermal growth factor receptor expression.
Schaefer G; Shao L; Totpal K; Akita RW
Cancer Res; 2007 Feb; 67(3):1228-38. PubMed ID: 17283159
[TBL] [Abstract][Full Text] [Related]
29. Matrix metalloproteinases in keratinocyte carcinomas.
Riihilä P; Nissinen L; Kähäri VM
Exp Dermatol; 2021 Jan; 30(1):50-61. PubMed ID: 32869366
[TBL] [Abstract][Full Text] [Related]
30. The interplay of HER2/HER3/PI3K and EGFR/HER2/PLC-γ1 signalling in breast cancer cell migration and dissemination.
Balz LM; Bartkowiak K; Andreas A; Pantel K; Niggemann B; Zänker KS; Brandt BH; Dittmar T
J Pathol; 2012 Jun; 227(2):234-44. PubMed ID: 22262199
[TBL] [Abstract][Full Text] [Related]
31. Nuclear HER3 is associated with favorable overall survival in uveal melanoma.
Trocmé E; Mougiakakos D; Johansson CC; All-Eriksson C; Economou MA; Larsson O; Seregard S; Kiessling R; Lin Y
Int J Cancer; 2012 Mar; 130(5):1120-7. PubMed ID: 21484789
[TBL] [Abstract][Full Text] [Related]
32. Presentation with multiple cutaneous basal cell carcinomas: association of glutathione S-transferase and cytochrome P450 genotypes with clinical phenotype.
Ramachandran S; Lear JT; Ramsay H; Smith AG; Bowers B; Hutchinson PE; Jones PW; Fryer AA; Strange RC
Cancer Epidemiol Biomarkers Prev; 1999 Jan; 8(1):61-7. PubMed ID: 9950241
[TBL] [Abstract][Full Text] [Related]
33. Morpheaform Basal Cell Carcinomas With Areas of Predominantly Single-Cell Pattern of Infiltration: Diagnostic Utility of p63 and Cytokeratin.
East E; Fullen DR; Arps D; Patel RM; Palanisamy N; Carskadon S; Harms PW
Am J Dermatopathol; 2016 Oct; 38(10):744-50. PubMed ID: 27043336
[TBL] [Abstract][Full Text] [Related]
34. Immunoexpression of p53 and COX-2 in basal cell carcinoma.
Enache AO; Stepan AE; Mărgăritescu C; Pătraşcu V; Ciurea RN; Simionescu CE; Camen A
Rom J Morphol Embryol; 2018; 59(4):1115-1120. PubMed ID: 30845292
[TBL] [Abstract][Full Text] [Related]
35. HER2/HER3 pathway in biliary tract malignancies; systematic review and meta-analysis: a potential therapeutic target?
Galdy S; Lamarca A; McNamara MG; Hubner RA; Cella CA; Fazio N; Valle JW
Cancer Metastasis Rev; 2017 Mar; 36(1):141-157. PubMed ID: 27981460
[TBL] [Abstract][Full Text] [Related]
36. The prognostic value of CXCR4, α-SMA and WASL in upper lip basal cell carcinomas.
Sălan AI; Mărăşescu PC; Camen A; Ciucă EM; Matei M; Florescu AM; Pădureanu V; Mărgăritescu C
Rom J Morphol Embryol; 2018; 59(3):839-849. PubMed ID: 30534824
[TBL] [Abstract][Full Text] [Related]
37. Micronodular basal cell carcinoma: a distinct subtype? Relationship with nodular and infiltrative basal cell carcinomas.
Betti R; Menni S; Radaelli G; Bombonato C; Crosti C
J Dermatol; 2010 Jul; 37(7):611-6. PubMed ID: 20629826
[TBL] [Abstract][Full Text] [Related]
38. Expression of metalloproteinases (MMP-2 and MMP-9) in basal-cell carcinoma.
Goździalska A; Wojas-Pelc A; Drąg J; Brzewski P; Jaśkiewicz J; Pastuszczak M
Mol Biol Rep; 2016 Oct; 43(10):1027-33. PubMed ID: 27406386
[TBL] [Abstract][Full Text] [Related]
39. Assessment of protein expression and gene status of human epidermal growth factor receptor (HER) family molecules in ameloblastomas.
Oikawa M; Miki Y; Shimizu Y; Kumamoto H
J Oral Pathol Med; 2013 May; 42(5):424-34. PubMed ID: 23278525
[TBL] [Abstract][Full Text] [Related]
40. Increased expression of COX-2 in recurrent basal cell carcinoma of the skin: a pilot study.
Karahan N; Baspinar S; Bozkurt KK; Caloglu E; Ciris IM; Kapucuoglu N
Indian J Pathol Microbiol; 2011; 54(3):526-31. PubMed ID: 21934214
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
